IQ EQ Fund Management’s Novartis NVS Stock Holding History

IQ EQ Fund Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,094	Closed	-$926K	–	302
2023 Q3	$926K	Sell	9,094 -5,373	-37%	-$545K	0.19%	145
2023 Q2	$1.46M	Hold	14,467	–	–	0.28%	105
2023 Q1	$1.33M	Sell	14,467 -1,129	-7%	-$98.6K	0.26%	112
2022 Q4	$1.41M	Buy	15,596 +776	+5%	+$65.4K	0.29%	106
2022 Q3	$1.13M	Sell	14,820 -2,981	-17%	-$247K	0.25%	118
2022 Q2	$1.5M	Buy	17,801 +854	+5%	+$74.9K	0.3%	114
2022 Q1	$1.49M	Buy	16,947 +2,300	+16%	+$199K	0.24%	127
2021 Q4	$1.28M	Buy	14,647 +1,337	+10%	+$111K	0.2%	140
2021 Q3	$1.09M	Sell	13,310 -7,596	-36%	-$683K	0.17%	147
2021 Q2	$1.91M	Buy	20,906 +5,235	+33%	+$466K	0.29%	109
2021 Q1	$1.34M	Buy	+15,671	New	+$1.41M	0.24%	142

Other funds holding NVS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IQ EQ Fund Management's NVS Position: Q4 2023 in Review

IQ EQ Fund Management sold out of Novartis (NVS) in Q4 2023, closing a stake of 9,094 shares — an estimated $926K sold.

IQ EQ Fund Management first reported a position in NVS in Q1 2021 and held it in 11 quarters. The position peaked at $1.91M in Q2 2021. 1,272 funds tracked by Wall St. Rank hold NVS as of Q4 2023.

IQ EQ Fund Management reported no remaining Novartis position as of Q4 2023 after selling out during the quarter.
IQ EQ Fund Management sold 9,094 Novartis shares in Q4 2023, an estimated $926K.
IQ EQ Fund Management first reported a position in Novartis in Q1 2021 and held it in 11 quarters.
IQ EQ Fund Management's Novartis position peaked at $1.91M in Q2 2021.
1,272 funds tracked by Wall St. Rank held Novartis as of Q4 2023.

Based on IQ EQ Fund Management's 13F filing for Q4 2023, filed 9 Feb 2024.